Ep 173: Ken Shreve: How To Buy Stocks With Bottoming Bases
Investing With IBD
Harmony Biosciences: A Stock That's Still Early Stage
The leaderboard model portfolio is about 23 percent in the medical sector. We're seeing broad based strength so Harmony Harmony biosciences looking at the weekly chart here first thing I like about this is that it's still early stage no matter how you look at it. Fund ownership has been increasing quite a bit in recent quarters don't have any IBD top funds in there but you are seeing meaningful meaningful increases in fund ownership.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
